Viewing Study NCT05514912

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-03-04 @ 9:54 PM
Study NCT ID: NCT05514912
Status: WITHDRAWN
Last Update Posted: 2023-12-26
First Post: 2022-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
Sponsor: Emory University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Intrahepatic Cholangiocarcinoma View
None Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 View
None Stage I Intrahepatic Cholangiocarcinoma AJCC v8 View
None Stage II Intrahepatic Cholangiocarcinoma AJCC v8 View
None Stage III Intrahepatic Cholangiocarcinoma AJCC v8 View
Keywords: